Delivery Order SPE2DB20D2104-SPE2DB24FU31A
Award Date
5/21/24
Potential Completion Date
5/22/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,592.52 Firm Fixed Price Delivery Order is for the supply of 4,567,058 units of Rosuvastatin Calcium 5 mg tablets. The award has an ultimate completion date of January 28, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $17,373.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Rosuvastatin Calcium 5 mg tablets in quantities of 500 tablets, with a completion date of April 18, 2023. This is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, identified as SPE2DB20D2014|SPE2DB24FA26F, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,228.46 firm fixed-price delivery order is for the supply of 500 units of Rosuvastatin Calcium 40 mg tablets. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $157,458.83 firm fixed-price delivery order is for the supply of Rosuvastatin Calcium 40 mg tablets, a cardiovascular medication, to support military healthcare programs. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $26,023.34 firm fixed-price delivery order contract is for the supply of 4,564,414,347 units of Rosuvastatin Calcium 20 mg tablets. The contract has an ultimate completion date of April 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ROSUVASTATIN CALCIUM 40 MG TAB 500S. The contract has a potential value of $16,652.31 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and will deliver the pharmaceutical products from its Corporate Office location in Conshohocken,...
This federal contract award is for the delivery of Rosuvastatin Calcium 5 mg tablets, with a total ceiling value of $87,732.43. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order with a firm fixed price, and the ultimate completion date is March 21, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,259.72, is a delivery order for the medication Crestor 40 mg tablet, with a completion date of February 24, 2025. The contract is a firm fixed-price arrangement with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract (SPE2DB22D3011|SPE2DB24FQ0FC) to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. The $35,103.25 contract is for the supply of 500 units of Rosuvastatin Calcium 5 mg tablets. This delivery order falls under AmerisourceBergen's existing indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 2025. AmerisourceBergen, a for-profit organization, serves...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $186,371.64 to Amerisourcebergen Drug Corporation for the supply of 500 units of Rosuvastatin Calcium 40mg tablets. Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 11, 2023 under the terms of the contract. As a leading provider of drug distribution and related services, Amerisourcebergen will utilize its extensive logistics network and supply chain...